This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
viewpoints
Welcome to Reed Smith's viewpoints — timely commentary from our lawyers on topics relevant to your business and wider industry. Browse to see the latest news and subscribe to receive updates on topics that matter to you, directly to your mailbox.
| 2 minutes read

Racial and ethnic disparities persist in lung cancer screening program

The U.S. Preventive Services Task Force (USPSTF) recently expanded its low-dose computed tomography (LDCT) lung cancer screening (LCS) eligibility criteria, but these revisions may not have been enough to improve racial and ethnic LCS disparities. In an original research article in the online edition of the journal Radiology, researchers from Mass General Hospital found that although the new LDCT LCS guidelines have increased eligibility overall (11% old vs. 14% new) and across most racial groups (Whites: 14% to 15%; African Americans: 7% to 9%; Hispanics: 4% to 5%), African Americans and Hispanics nevertheless remain significantly less likely to be eligible for screening studies than do Whites.

In March, the USPSTF modified its lung cancer screening guidelines to recommend prior smokers start screening at age 50, rather than 55. The task force also reduced the pack years of smoking history that make someone eligible for screening from 30 pack years to 20 pack years (one pack year = smoking one pack per day for one year; 1 pack = 20 cigarettes). Thus, the USPSTF recommends yearly screening using an LDCT scan for people aged 50 to 80 years old who are at high risk for lung cancer because of their smoking history.

The researchers note that neither the previous nor the revised USPSTF LCS guidelines incorporate important risk factors of race and ethnicity and socioeconomic status. African American and Hispanic smokers become eligible for LCS when their risk of lung cancer is higher than that of Whites, thus perpetuating inequities in health care access and preventing early intervention in these high-risk groups. The authors believe that the effectiveness of lung cancer screening in the diverse U.S. population would be increased if LCS eligibility criteria included variables such as race and ethnicity, socio-demographic variables, and other predictors of lung cancer risk.

In a separate editorial in the same issue of Radiology, researchers from the Division of Cancer Treatment and Diagnosis and the Center to Reduce Cancer Health Disparities at the National Cancer Institute, recommend that more be done to address the deep disparities that continue to exist in lung cancer screening eligibility.

Additionally, the Centers for Medicare and Medicaid Services (CMS) also needs to update its payment criteria. Currently, to be eligible for payment for the screening, a Medicare beneficiary must:

  • Be 55 – 77 years old;
  • Be asymptomatic (no signs or symptoms of lung cancer);
  • Have a tobacco smoking history of at least 30 pack years;
  • Be a current smoker or one who has quit smoking within the last 15 years; and
  • Receive a written order for LDCT lung cancer screening.

Additionally, CMS has not yet removed barriers to the performance of LDCT lung cancer screening services by independent diagnostic testing facilities (IDTFs).

To address racial and ethnic disparities, revised U.S. Preventive Services Task Force (USPSTF) recommendations lowered lung cancer screening (LCS) eligibility thresholds. Using cross-sectional survey data from 20 states, African American respondents (adjusted odds ratio [OR]: 0.39; 95% CI: 0.32, 0.47; P

Tags

health care & life sciences, lung cancer, screening, disparities

Related Insights